Why is "Atopic dermatitis" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-18 02:07:51
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Atopic dermatitis (AD), also known as atopic eczema, is a long-term type of inflammation of the skin. Atopic dermatitis is also often called simply eczema, but "eczema" is also used to refer to dermatitis, the larger group of skin conditions. Atopic dermatitis results in itchy, red, swollen, and cracked skin. Clear fluid may come from the affected areas, which can thicken over time.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
GLOBOSTAD: 3 Year Efficacy of Dupilumab in Atopic Dermatitis, With Silvia Mariel Ferrucci, MD - HCPLive
-
Early Atopic Dermatitis Linked to Higher Asthma Risk - EMJ
-
Could Dupilumab Treat Depression? Mount Sinai Study Targets Immune Link - Dermatology Times
-
Atopic Dermatitis Severity tied to Sexual Health disorders, suggests study - Medical Dialogues
-
A Look At Organon (OGN) Valuation After VTAMA Wins Key Pediatric Atopic Dermatitis Endorsement - simplywall.st
-
Asthma prevalence and risk factors in early-onset atopic dermatitis using Korean National Health Insurance Service data - Nature
-
Can Children's Allergic Rhinitis Be Prevented? - MedPage Today
-
Lebrikizumab Improves Pediatric Atopic Dermatitis in Phase 3 Trial - Medical Professionals Reference
-
AAD issues pediatric atopic dermatitis guidelines for optimal patient care - Contemporary Pediatrics
-
What People of Color Should Know About Joining an Atopic Dermatitis Clinical Trial - Everyday Health
-
Tralokinumab Shows Strong Real-World Efficacy in Atopic Dermatitis for Patients With Skin of Color: April Armstrong, MD, MPH - AJMC
-
Ocular Surface DIsorders More Common in Those with Atopic Dermatitis, Research Says - Review of Optometry
-
Targeting the JAK/STAT pathway in atopic dermatitis - Frontiers
-
Stapokibart for Adolescent Patients With Moderate to Severe Atopic Dermatitis - Docwire News
-
Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases - BioSpace
-
What's New in Atopic Dermatitis Management, With April Armstrong, MD, MPH - HCPLive
-
Multi-modal skin atlas identifies a multicellular immune-stromal community associated with disrupted cornification and specific T cell expansion in atopic dermatitis - Nature
-
Stapokibart Shows Potential for Pediatric Patients With Atopic Dermatitis - Docwire News
-
Dermatology Times 2025 Year in Review: Atopic Dermatitis - Dermatology Times
-
Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy - Frontiers
-
Explaining the mental-health burden of atopic dermatitis - Nature
-
Gene Expression Profile Helps Predict Atopic Dermatitis Therapy Response - AJMC
-
European Atopic Eczema Guidelines Update Includes New, Expanded Drug Approvals - Dermatology Advisor
-
Stress mediates the association between atopic dermatitis and sleep duration in Korean adults - Nature
-
Personalizing Atopic Dermatitis Treatment in a Growing Landscape: April Armstrong, MD, MPH - AJMC
-
JAK-1 inhibitors in the management of atopic dermatitis in patients over 65 years old: a descriptive cohort study - Nature
-
Bispecific and trispecific antibodies in atopic dermatitis: a review of the emerging clinical pipeline - Frontiers
-
Staged Approach Suggested for Patient Decision Aid in Atopic Dermatitis - Rheumatology Advisor
-
Investigation of neutrophil infiltration in the acute canine atopic dermatitis model - Frontiers
-
AAD recommends Organon’s VTAMA cream for pediatric atopic dermatitis - Investing.com
-
Atopic dermatitis-alleviating effects of lactiplantibacillus plantarum LRCC5195 paraprobiotics through microbiome modulation and safety assessment via genomic characterization and in vitro analysis - Nature
-
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025 - Dermatology Times
-
Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
-
5 Ways to Help Your Child Manage Atopic Dermatitis When They’re at School - Everyday Health
-
FDA Approves Difamilast as New Topical PDE4 Inhibitor for Atopic Dermatitis - Pharmacy Times
-
The significance of component-resolved diagnostics in atopic dermatitis - Frontiers
-
Atopic Dermatitis Treatment Burnout Is a Real Thing - Everyday Health
-
Phase 3 Trials Support Amlitelimab for Moderate to Severe Atopic Dermatitis - MPR - Medical Professionals Reference
-
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight - Yahoo Finance
-
New REZOLVE-AD Maintenance Data in Atopic Dermatitis Demonstrate Rezpegaldesleukin Resulted in Durable and New Responses Across Key Disease Measurements with Both Monthly and Quarterly Dosing - PR Newswire
-
Magnitude of atopic dermatitis and associated factors among children in northwest Ethiopia - Nature
-
Castle Biosciences Launches Test to Guide Atopic Dermatitis Treatment Selection - Clinical Lab Products
-
Rezpegaldesleukin maintenance data show durable responses in moderate-to-severe atopic dermatitis - Contemporary Pediatrics
-
Clinical Trial Data Signal a New Era for Atopic Dermatitis, Melanoma, and Psoriasis - AJMC
-
Navigating Steroid Safety and New Options in Pediatric Atopic Dermatitis - Dermatology Times
-
How to Speed Up Your Morning Atopic Dermatitis Routine - Everyday Health
-
The Atopic Dermatitis Patient Journey: From Awareness to Advanced Care - Cureus
-
Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database - Frontiers
-
Living with Atopic Dermatitis: Jade's Story - Sanofi
-
Targeting OX40: rocatinlimab—a novel therapy for atopic dermatitis - The Lancet
-
When a child lives with atopic dermatitis: an integrative literature review on parental experience - Frontiers
-
Lebrikizumab proves benefit in phase 3 pediatric atopic dermatitis trial - Contemporary Pediatrics
-
Only steroid-free cream AAD backs for all child eczema severities - Stock Titan
-
Atopic Dermatitis Treatment Challenges: Pediatric vs. Adult Patient Management and Healthcare Resource Utilization - AJMC
-
Patient Decision Aid Aims to Improve Treatment Selection in Atopic Dermatitis - AJMC
-
Navigating Available Topical Treatment Options for Pediatric Atopic Dermatitis - AJMC
-
Disease-Modifying Topicals Redefine Atopic Dermatitis Management - Dermatology Times
-
PDE4 Inhibitors for Atopic Dermatitis: How Do They Work? - Dermatology Times
-
Nektar’s Rezpeg Differentiates in Atopic Dermatitis With Durable, Deep Responses in Mid-Stage - BioSpace
-
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials - The Lancet
-
Urbanization, Lifestyle, and Skin Barrier Damage in Atopic Dermatitis - HMP Global Learning Network
-
Tralokinumab in Moderate-to-Severe Atopic Dermatitis: The Latest Data - EMJ
-
Closing: Future of Pediatric Atopic Dermatitis Management: Real-World Evidence Needs and Clinical Takeaways - AJMC
-
The Role of Fibroblasts in Atopic Dermatitis | JIR - Dove Medical Press
-
Prenatal exposure to endocrine-disrupting chemicals and childhood atopic dermatitis: epidemiological evidence - Frontiers
-
Safe Medical Management of Atopic Dermatitis in Pregnancy and Lactation - EMJ
-
How to Care for Atopic Dermatitis Wounds - Everyday Health
-
Acta Paediatrica | Paediatrics Journal - Wiley Online Library
-
Atopic dermatitis, primary atopic disorders, and the cutaneous microbiome: current understanding of an expanding field - Frontiers
-
Value of Achieving Minimal Disease Activity in Atopic Dermatitis - EMJ
-
FDA Approves Ruxolitinib Cream for Patients as Young as 2 Years With Atopic Dermatitis - AJMC
-
Breaking the ‘Flare-Fix’ Cycle: Is It Time to Switch Your Atopic Dermatitis Treatment? - Everyday Health
-
Atopic dermatitis-related anti-inflammatory in vitro effects of a plant extract mixture - Nature
-
6 Early Signs of an Atopic Dermatitis Flare in Children - Everyday Health
-
Multidisciplinary Team Approach to Atopic Dermatitis: Diagnosis and Coordinated Care Strategies - AJMC
-
Minimal Disease Activity Sustained in Atopic Dermatitis - EMJ
-
How Parents Can Help Children With Severe Atopic Dermatitis (Eczema) - Everyday Health
-
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years - AJMC
-
Atopic Dermatitis Skin Clearance Maintained Over 3 Years With Lebrikizumab - AJMC
-
Association of cesarean section with asthma and atopic dermatitis in infants from the Japan Environment and Children’s Study | Scientific Reports - Nature
-
New treatments for atopic dermatitis: innovation and effectiveness for your skin - Hospital Clínic Barcelona
-
Yearly Flares in Atopic Dermatitis May Predict Disease Severity - AJMC
-
Pediatric Atopic Dermatitis Education: Lifestyle Modifications and Topical Therapy Management - AJMC
-
The ‘High-Functioning’ Flare: Why Settling for ‘Good Enough’ Atopic Dermatitis Care Is Costing You - Everyday Health
-
How Scalp Atopic Dermatitis Differs From Other Skin Conditions - health.com
-
A self-powered hydration-monitoring and drug-delivery skin patch for closed-loop treatment of atopic dermatitis - Nature
-
Clarifying the Role of IL-13 Inhibitors in Atopic Dermatitis: Clinical Profiles, Comparisons, and Real-World Application - HMP Global Learning Network
-
Atopic Dermatitis Linked to S1P Immune Signalling - EMJ
-
Abrocitinib Shows Long-Term Success in Atopic Dermatitis - EMJ
-
NFATc1 deficiency in B cells ameliorates atopic dermatitis - Nature
-
The Evolving Atopic Dermatitis Treatment Landscape - EMJ
-
Addressing the Burden of Atopic Dermatitis on the Head and Neck - EMJ
-
AAD updates recommendations for treating atopic dermatitis - Healio
-
Pediatric Atopic Dermatitis Treatment Selection: Biologics vs Nonsteroidal Topical Therapies - AJMC
-
Long-Term Lebrikizumab Provides Sustained Skin Clearance in Atopic Dermatitis - AJMC
-
Air Pollution Linked to Worse Atopic Dermatitis - AJMC
-
Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis - Business Wire
-
Innovative microbial strategies in atopic dermatitis - Frontiers
-
How to Change Bath Time for Your Child With Atopic Dermatitis (Eczema) - Everyday Health
-
LEO Pharma Presents Late-Breaking Results on Temtokibart for Atopic Dermatitis at EADV - Dermatology Times
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.